Clinical trial
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive…
NCT00099294 · Threshold Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00099294 |
|---|---|
| Title | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer |
| Official title | A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine |
| Lead sponsor | Threshold Pharmaceuticals, Industry |
| Collaborators | PPD Development, LP Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Glufosfamide |
| Enrollment | 300 |
| Start date | Sep 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Dec 10, 2004 |
| Last update posted | Apr 30, 2009 |
| Countries | Argentina, Brazil, Bulgaria, Czechia, Hungary, India, Mexico, Romania, Russia, Ukraine, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: